Sherman will often ask is whether the medication is still having its intended effect on hunger and appetite or if its producing the amount of weight loss expected, he says
The interpretation has been a continuing area of discussion
To join GLP-1 Connect, visit About Inspire Founded in 2005, Inspire is the worlds largest online community for patients and caregivers
Authors relationships and activities SCB received honoraria and teaching and research sponsorship/grants from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, MSD, Novo Nordisk, Pfizer, Sanofi and Takeda
Mice were used for single experiments, except the same groups of mice were used for measuring thermal and mechanical nociception and for the effects of different pharmacological compounds
Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors